RB
NVO

Rodgers Brothers’s Novo Nordisk NVO Stock Holding History

Rodgers Brothers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Sell
42,450
-3,100
-7% -$133K 0.2% 103
2026
Q1 		$1.67M Sell
45,550
-1,800
-4% -$85.3K 0.19% 114
2025
Q4 		$2.41M Buy
+47,350
New +$2.42M 0.29% 89

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rodgers Brothers's NVO Position: Q2 2026 in Review

Rodgers Brothers reduced its Novo Nordisk (NVO) stake by 6.8% in Q2 2026, selling an estimated $133K and leaving 42,450 shares worth $2.04M. The position accounts for 0.2% of the portfolio, ranked #103.

Rodgers Brothers first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.41M in Q4 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Rodgers Brothers held 42,450 shares of Novo Nordisk worth $2.04M as of Q2 2026.
  • Rodgers Brothers sold 3,100 Novo Nordisk shares in Q2 2026, an estimated $133K.
  • Novo Nordisk made up 0.2% of Rodgers Brothers's portfolio in Q2 2026, its #103 holding.
  • Rodgers Brothers first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • Rodgers Brothers's Novo Nordisk position peaked at $2.41M in Q4 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Rodgers Brothers's 13F filing for Q2 2026, filed 5 Aug 2026.